Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

marvel biosciences corp.

POPULAR ARTICLES

Marvel Biosciences Announces Closing of Convertible Debenture Offering

Marvel Biosciences Announces Closing of Convertible Debenture Offering

Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

LATEST ARTICLES

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Sponsors Scientific Meeting on Purines

Marvel Biosciences Sponsors Scientific Meeting on Purines

Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204

Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204

Latest News

Coelacanth Energy Increases Previously Announced Bought Deal Public Offering to C$80M

American Uranium Expands its Lo Herma ISR Uranium Project in Wyoming's Powder River Basin as Company Secures Strategically Located Uranium Mineral Rights and Stakes Additional Mining Claims

Canadian Investment Regulatory Organization Trade Resumption - CEI

SAGA Metals Secures Maximum JEA Grant for Labrador and Adopts Semi-Annual Financial Reporting

Trading Halt

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Pinnacle Silver and Gold

Pinnacle Silver and Gold (PINN:CC)

PINN:CC

Skyharbour Resources

Skyharbour Resources (SYH:CC)

SYH:CC

Silver Hammer Mining

Silver Hammer Mining (HAMR:CC)

HAMR:CC

Angkor Resources

Angkor Resources (ANK:CC)

ANK:CC

Generation Uranium

Generation Uranium (GEN:CC)

GEN:CC

Prime Medicine

PRME

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES